| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/02/2009 | CA2708447A1 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition |
| 07/02/2009 | CA2707646A1 Alpha-aminoamide derivatives useful in the treatment of psychiatric disorders |
| 07/02/2009 | CA2707447A1 Sulfonyl-substituted 6-membered ring derivative |
| 07/02/2009 | CA2705411A1 Heteroaryl derivatives as orexin receptor antagonists |
| 07/02/2009 | CA2704268A1 Receptor targeting ligands |
| 07/01/2009 | EP2075255A1 Human FGF-23 gene and gene expression products |
| 07/01/2009 | EP2075254A1 Therapeutic use of a growth factor, NsG33 |
| 07/01/2009 | EP2075007A2 Treatment for Alzheimer's disease |
| 07/01/2009 | EP2075004A1 Use of epidermal growth factor for the morphofunctional restoration of peripheral nerves in diabetic neuropathy |
| 07/01/2009 | EP2074998A2 Use of cyclic bioisosteres of purine system derivatives for the treatment of diseases caused by disorders of nitrergic and dopaminergic systems |
| 07/01/2009 | EP2074997A1 Use of Asimadoline for the treatment of digestive disorders |
| 07/01/2009 | EP2074996A1 Synergistic compositions with analgesic properties comprising n-acylated 4-hydroxyphenylamine derivatives |
| 07/01/2009 | EP2074995A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| 07/01/2009 | EP2074142A1 Compounds for stimulating p-glycoprotein function and uses thereof |
| 07/01/2009 | EP2074138A1 Neuroprotective peptide inhibitors of ap-1 signaling and uses therefor |
| 07/01/2009 | EP2074127A1 Pyrazolo [1, 5-a]pyrimidine derivatives and their therapeutic use |
| 07/01/2009 | EP2074123A1 Novel anxiolytic compounds |
| 07/01/2009 | EP2074117A2 Heteromonocyclic compound and use thereof |
| 07/01/2009 | EP2074105A1 Cyclopropyl-piperazine compounds as calcium channel blockers |
| 07/01/2009 | EP2074092A2 Inhibitors of d-amino acid oxidase |
| 07/01/2009 | EP2074091A1 [2-(6-flouro-1h-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders |
| 07/01/2009 | EP2074088A2 N-substituted-azacyclylamines as histamine-3 antagonists |
| 07/01/2009 | EP2074086A1 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
| 07/01/2009 | EP2074082A1 Polymorphs of o-desmethyl venlafaxine succinate |
| 07/01/2009 | EP2073898A1 Complement inhibition for improved nerve regeneration |
| 07/01/2009 | EP2073897A2 Compositions and methods for modulating tlr14 activity |
| 07/01/2009 | EP2073846A1 Combined therapies of antipsychotic drugs and tetracyclines in the treatment of psychiatric disorders |
| 07/01/2009 | EP2073833A2 Treatment of demyelinating disorders with soluble lymphotoxin-beta-receptor |
| 07/01/2009 | EP2073813A2 Composition s comprising a benzodiazepine, an alcohol aversive agent and an abuse aversive agent |
| 07/01/2009 | EP2073812A2 Histone acetyle transferase activators and histone deacetylase inhibitors in the treatment of alcoholism |
| 07/01/2009 | EP2073804A2 Hydroxy-substituted benzoic acid amide compounds for use in therapy |
| 07/01/2009 | EP2073801A1 Methods of stimulating cellular growth, synaptic remodeling and consolidation of long-term memory |
| 07/01/2009 | EP2073799A2 Novel agents of calcium ion channel modulators |
| 07/01/2009 | EP2073798A2 Pharmaceutical nimodipine compositions |
| 07/01/2009 | EP2073797A2 Pharmaceutical compositions |
| 07/01/2009 | EP1868999B1 Pyridine-3-carboxamide derivatives as cb1 inverse agonists |
| 07/01/2009 | EP1858852B1 Heteroarylsulfonyl stilbenes as 5-ht2a antagonists |
| 07/01/2009 | EP1784393B1 Quinazolines useful as modulators of ion channels |
| 07/01/2009 | EP1740583B1 Oxadiazolone derivatives as ppar delta agonists |
| 07/01/2009 | EP1623719B1 Treatment of alzheimer's disease and cerebral amyloid angiopathy |
| 07/01/2009 | EP1613296B1 Methods for treatment of parkinson's disease |
| 07/01/2009 | EP1611104B1 Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists |
| 07/01/2009 | EP1529116B1 Method for predicting the responsiveness to treatment with rivastigmine based on the ApoE genotyp of dementia patients |
| 07/01/2009 | EP1503998B1 Heteroaryl substituted spirocyclic sufamides for inhibition of gamma secretase |
| 07/01/2009 | EP1471054B1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 07/01/2009 | EP1414428B1 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 07/01/2009 | EP1408954B1 Carbamate compounds for use in preventing or treating neuropathic pain |
| 07/01/2009 | EP1406858B1 Substituted 4-aminocyclohexanols |
| 07/01/2009 | EP1381367A4 Aripiprazole oral solution |
| 07/01/2009 | EP1315417B1 Mutant non-human mammal for expressing the alpha6 acetylcholine nicotinic receptor subunit and use for screening substances capable of interacting with said receptor |
| 07/01/2009 | EP1203025B1 Novel method and composition for inhibition of angiogenesis using antagonists based on mmp-9 and beta1 integrins |
| 07/01/2009 | EP1124846B1 Nucleotide and protein sequences of nogo genes and methods based thereon |
| 07/01/2009 | EP0915973B1 Gene involved in cadasil, method of diagnosis and therapeutic application |
| 07/01/2009 | CN101468999A New polymorphs of olanzapine hydrochloride |
| 07/01/2009 | CN100506845C IFNAR2 mutants, their production and use |
| 07/01/2009 | CN100506835C Segment of alginic acid oligosaccharide, preparation method and application |
| 07/01/2009 | CN100506813C Remedies |
| 07/01/2009 | CN100506801C Inhibitors of glycogen synthase kinase 3 |
| 07/01/2009 | CN100506797C Monohydroxycarbamazepine for use in the preparation of a medicament for the treatment of affective and attention disorder and neuropathic pain |
| 07/01/2009 | CN100506791C Pentafluorosulfanylbenzoylguanidines, preparation method, their use as medicaments or diagnostic aids, and medicaments comprising them |
| 07/01/2009 | CN100506790C Modafinil polymorphic forms |
| 07/01/2009 | CN100506788C Arylalkylcarbamate derivatives production and use thereof in therapy |
| 07/01/2009 | CN100506776C NK1 antagonists |
| 07/01/2009 | CN100506277C Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 07/01/2009 | CN100506229C Piperidin-2,6-dione salts and its use in the treatment of stress-related affective disorders |
| 07/01/2009 | CN100506220C Methods for preventing and treating peripheral neuropathy by administering desmethylselegiline |
| 07/01/2009 | CN100506092C Beverage with Chinese medicines for relieving alcoholism |
| 07/01/2009 | CN100506060C One-step process for preparing gum |
| 06/30/2009 | US7553971 Aryl aniline β2 adrenergic receptor agonists |
| 06/30/2009 | US7553966 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/30/2009 | US7553918 pH-sensitive polymer |
| 06/30/2009 | US7553867 Furan or thiophene derivative and medicinal use thereof |
| 06/30/2009 | US7553852 Caspase inhibitors and uses thereof |
| 06/30/2009 | US7553851 2-(1-Azabicyclo[2.2.2]oct-3-yl)-N-(7-bromo-1-benzothien-2-yl)acetamide hydrochloride; nicotinic receptor agonists; cognition activators; learning enhancement; nootropic agents; demetia; cholinergic agents; Alzheimer's disease; brain traumas; stroke; attention deficit disorder; schizophrenia |
| 06/30/2009 | US7553847 Treating obsessive-compulsive disorder, acute stress disorder, post traumatic stress disorder, social anxiety disorder, somatization disorder; 2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone |
| 06/30/2009 | US7553831 Beta-secretase inhibitors; inhibiting cleavage of amyloid precursor protein (APP); hydroxy-functional disubstituted amines such as 6-(([[(2S,3S)-4-(3,5-difluorophenyl)-3-((3-[(dipropylamino)carbonyl]benzoyl)amino)-2-hydroxybutyl](ethyl)amino]carbonyl)amino)hexanoic acid |
| 06/30/2009 | US7553663 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 06/30/2009 | US7553660 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 06/30/2009 | US7553613 Coagulation, mechanical agitation; filtration |
| 06/30/2009 | CA2406833C Effervescent granules and methods for their preparation |
| 06/30/2009 | CA2368812C Combination of glucosylceramide synthesis inhibitors and glycolipid degrading enzyme in therapy |
| 06/30/2009 | CA2108119C Glial mitogenic factors, their preparation and use |
| 06/25/2009 | WO2009079391A1 Benzofuran anilide histone deacetylase inhibitors |
| 06/25/2009 | WO2009079225A1 Cyclopropyl amine derivatives |
| 06/25/2009 | WO2009079007A1 Stem-like cells and method for reprogramming adult mammalian somatic cells |
| 06/25/2009 | WO2009078481A1 Bicyclic heterocyclic derivative |
| 06/25/2009 | WO2009078445A1 Pharmaceutical preparation |
| 06/25/2009 | WO2009078432A1 1-alkyl-4-amino-1h-pyrazole-3-carboxamide compound |
| 06/25/2009 | WO2009077858A2 Hemioxalate salt of eletriptan |
| 06/25/2009 | WO2009077585A1 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 06/25/2009 | WO2009077584A1 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as opioid receptor ligands |
| 06/25/2009 | WO2009077574A1 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as opioid receptor ligands |
| 06/25/2009 | WO2009077559A2 5-oxo-3-pyrrolidinecarboxamide derivatives as p2x7 modulators |
| 06/25/2009 | WO2009077367A1 Novel pyrazole-substituted arylamides |
| 06/25/2009 | WO2009077365A1 Novel imidazole-substituted arylamides |
| 06/25/2009 | WO2009076965A1 Sertindole for the treatment of mania-related disorders |
| 06/25/2009 | WO2009076962A1 Therapeutic uses of compounds having affinity to the serotonin transporter, serotonin receptors and noradrenalin transporter |
| 06/25/2009 | WO2009076961A1 4-[2,3-difluoro-6-(2-fluoro-4-methyl-phenylsulfanyl)-phenyl]-piperidine |
| 06/25/2009 | WO2009061744A3 4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases |
| 06/25/2009 | WO2009046875A3 Combination of splenopentin and thymopentin and the use thereof in medicine |